
Nicole Erin Kinsey White
Examiner (ID: 18489, Phone: (571)272-9943 , Office: P/1648 )
| Most Active Art Unit | 1648 |
| Art Unit(s) | 1671, 1672, 1648 |
| Total Applications | 1130 |
| Issued Applications | 560 |
| Pending Applications | 136 |
| Abandoned Applications | 472 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17228996
[patent_doc_number] => 20210355552
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-18
[patent_title] => PAPER-BASED COLORIMETRIC COVID-19/SARS-COV-2 TEST
[patent_app_type] => utility
[patent_app_number] => 17/319845
[patent_app_country] => US
[patent_app_date] => 2021-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6341
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17319845
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/319845 | Paper-based colorimetric COVID-19/SARS-COV-2 test | May 12, 2021 | Issued |
Array
(
[id] => 17213156
[patent_doc_number] => 20210346492
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-11
[patent_title] => SARS-CoV-2 Vaccines
[patent_app_type] => utility
[patent_app_number] => 17/317279
[patent_app_country] => US
[patent_app_date] => 2021-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17169
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17317279
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/317279 | SARS-CoV-2 Vaccines | May 10, 2021 | Abandoned |
Array
(
[id] => 17215745
[patent_doc_number] => 20210349083
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-11
[patent_title] => CORONAVIRUS IgG/IgM MULTIPLEXED DUAL PATH IMMUNOASSAY DEVICE
[patent_app_type] => utility
[patent_app_number] => 17/316363
[patent_app_country] => US
[patent_app_date] => 2021-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9349
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17316363
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/316363 | Coronavirus IgG/IgM multiplexed dual path immunoassay device | May 9, 2021 | Issued |
Array
(
[id] => 18675703
[patent_doc_number] => 20230313325
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => METHODS FOR DETECTION OF PATHOGENIC INFECTIONS USING RED BLOOD CELL-CONTAINING PATIENT SAMPLES
[patent_app_type] => utility
[patent_app_number] => 17/997742
[patent_app_country] => US
[patent_app_date] => 2021-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22226
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17997742
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/997742 | METHODS FOR DETECTION OF PATHOGENIC INFECTIONS USING RED BLOOD CELL-CONTAINING PATIENT SAMPLES | May 6, 2021 | Pending |
Array
(
[id] => 18497807
[patent_doc_number] => 20230220499
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => METHODS AND COMPOSITIONS FOR DETECTING SARS-COV-2 NUCLEIC ACID
[patent_app_type] => utility
[patent_app_number] => 17/997919
[patent_app_country] => US
[patent_app_date] => 2021-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22476
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17997919
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/997919 | METHODS AND COMPOSITIONS FOR DETECTING SARS-COV-2 NUCLEIC ACID | May 6, 2021 | Pending |
Array
(
[id] => 17213155
[patent_doc_number] => 20210346491
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-11
[patent_title] => METHOD FOR THE PROPHYLAXIS OR TREATMENT OF CORONAVIRUS INFECTION USING AN IMMUNOMODULATOR AND VACCINE COMPOSITIONS COMPRISING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/314135
[patent_app_country] => US
[patent_app_date] => 2021-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4635
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17314135
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/314135 | Method for the prophylaxis or treatment of coronavirus infection using an immunomodulator and vaccine compositions comprising the same | May 6, 2021 | Issued |
Array
(
[id] => 18406898
[patent_doc_number] => 20230168249
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-01
[patent_title] => RECOMBINANT ANTIBODIES, KITS COMPRISING THE SAME, AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/922590
[patent_app_country] => US
[patent_app_date] => 2021-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10196
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 199
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17922590
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/922590 | RECOMBINANT ANTIBODIES, KITS COMPRISING THE SAME, AND USES THEREOF | May 3, 2021 | Pending |
Array
(
[id] => 18739920
[patent_doc_number] => 20230348888
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => MOLECULAR TRANSPORT FOR VIRAL AGENTS
[patent_app_type] => utility
[patent_app_number] => 17/923118
[patent_app_country] => US
[patent_app_date] => 2021-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25285
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17923118
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/923118 | MOLECULAR TRANSPORT FOR VIRAL AGENTS | May 2, 2021 | Pending |
Array
(
[id] => 18420131
[patent_doc_number] => 20230174592
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => DETECTION REAGENT FOR SCREENING BLOCKING AGENT OF CORONAVIRUS INFECTIONS, AND DETECTION METHOD
[patent_app_type] => utility
[patent_app_number] => 17/997465
[patent_app_country] => US
[patent_app_date] => 2021-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14209
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -71
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17997465
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/997465 | DETECTION REAGENT FOR SCREENING BLOCKING AGENT OF CORONAVIRUS INFECTIONS, AND DETECTION METHOD | Apr 29, 2021 | Pending |
Array
(
[id] => 17749638
[patent_doc_number] => 20220227842
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2022-07-21
[patent_title] => CLEAVING PRE-FUSION STATE SARS-COV-2 SPIKE PROTEIN
[patent_app_type] => utility
[patent_app_number] => 17/242364
[patent_app_country] => US
[patent_app_date] => 2021-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10015
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17242364
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/242364 | Cleaving pre-fusion state SARS-CoV-2 spike protein | Apr 27, 2021 | Issued |
Array
(
[id] => 17749638
[patent_doc_number] => 20220227842
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2022-07-21
[patent_title] => CLEAVING PRE-FUSION STATE SARS-COV-2 SPIKE PROTEIN
[patent_app_type] => utility
[patent_app_number] => 17/242364
[patent_app_country] => US
[patent_app_date] => 2021-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10015
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17242364
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/242364 | Cleaving pre-fusion state SARS-CoV-2 spike protein | Apr 27, 2021 | Issued |
Array
(
[id] => 18406896
[patent_doc_number] => 20230168247
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-01
[patent_title] => SPECIFICITY ENHANCING REAGENTS FOR COVID-19 ANTIBODY TESTING
[patent_app_type] => utility
[patent_app_number] => 17/921039
[patent_app_country] => US
[patent_app_date] => 2021-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21328
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17921039
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/921039 | SPECIFICITY ENHANCING REAGENTS FOR COVID-19 ANTIBODY TESTING | Apr 25, 2021 | Pending |
Array
(
[id] => 17171720
[patent_doc_number] => 20210325390
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-21
[patent_title] => Virus detection
[patent_app_type] => utility
[patent_app_number] => 17/233479
[patent_app_country] => US
[patent_app_date] => 2021-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5930
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17233479
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/233479 | Virus detection | Apr 16, 2021 | Abandoned |
Array
(
[id] => 18352375
[patent_doc_number] => 20230140486
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => FUSION PROTEIN AND METHOD OF DETECTING BACTERIA HAVING PSEUDAMINIC ACID
[patent_app_type] => utility
[patent_app_number] => 17/913473
[patent_app_country] => US
[patent_app_date] => 2021-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6131
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17913473
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/913473 | FUSION PROTEIN AND METHOD OF DETECTING BACTERIA HAVING PSEUDAMINIC ACID | Apr 13, 2021 | Pending |
Array
(
[id] => 18406161
[patent_doc_number] => 20230167512
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-01
[patent_title] => RNA VIRUS DIAGNOSTIC ASSAY
[patent_app_type] => utility
[patent_app_number] => 17/995785
[patent_app_country] => US
[patent_app_date] => 2021-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10099
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17995785
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/995785 | RNA VIRUS DIAGNOSTIC ASSAY | Apr 11, 2021 | Abandoned |
Array
(
[id] => 17124468
[patent_doc_number] => 20210299236
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-30
[patent_title] => Methods and Compositions for Enhancing Vaccine Immune Responses
[patent_app_type] => utility
[patent_app_number] => 17/227350
[patent_app_country] => US
[patent_app_date] => 2021-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21861
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17227350
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/227350 | Methods and Compositions for Enhancing Vaccine Immune Responses | Apr 10, 2021 | Abandoned |
Array
(
[id] => 18537504
[patent_doc_number] => 20230242598
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => FUNCTIONAL POLYPEPTIDES AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/642339
[patent_app_country] => US
[patent_app_date] => 2021-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18858
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17642339
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/642339 | FUNCTIONAL POLYPEPTIDES AND USE THEREOF | Apr 6, 2021 | Abandoned |
Array
(
[id] => 17154938
[patent_doc_number] => 20210315989
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-14
[patent_title] => METHODS TO PREPARE NASOPHARYNGEAL AND ORAL MATERIAL FOR ORAL INOCULATION OF COVID-19
[patent_app_type] => utility
[patent_app_number] => 17/223920
[patent_app_country] => US
[patent_app_date] => 2021-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3439
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17223920
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/223920 | Methods to prepare nasopharyngeal and oral material for oral inoculation of COVID-19 | Apr 5, 2021 | Issued |
Array
(
[id] => 18852728
[patent_doc_number] => 11850280
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-12-26
[patent_title] => Oral vaccine for peste-des-petits-ruminants virus
[patent_app_type] => utility
[patent_app_number] => 17/218939
[patent_app_country] => US
[patent_app_date] => 2021-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 12624
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17218939
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/218939 | Oral vaccine for peste-des-petits-ruminants virus | Mar 30, 2021 | Issued |
Array
(
[id] => 16961455
[patent_doc_number] => 20210212954
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-15
[patent_title] => MEMBRANE LIPID COATED NANOPARTICLES AND METHOD OF USE
[patent_app_type] => utility
[patent_app_number] => 17/209000
[patent_app_country] => US
[patent_app_date] => 2021-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5225
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17209000
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/209000 | Membrane lipid coated nanoparticles and method of use | Mar 21, 2021 | Issued |